Manufacturing news briefs – stories you might have missed

Cell Therapies to manufacture Kymriah Melbourne contract manufacturer Cell Therapies has been given Therapeutic Goods Administration approval to manufacture Novartis’ chimeric antigen receptor T-cell at its facility at the Peter MacCallum Cancer Centre. The one-off treatment for blood cancers involves removing cells from the patient, reprogramming them and infuysing them back into the body. The…